Reverse in Biological Technology

INVO Bioscience Completes Reverse Merger

Shares trading under IVOB symbol on OTCBB BEVERLY, Mass., Feb. 25 /PRNewswire-FirstCall/ -- INVO Bioscience, Inc. ("INVO Bioscience" or "the company"), focused on creating simplified, lower cost treatment option for patients diagnosed with infertility, announced the closing of its reverse mer...

Novel Diabetes Drug Discovery Has Potential to Reverse Disease

WYNNEWOOD, Pa., Jan. 27 /PRNewswire/ -- A study released today in Endocrine Practice (2008;14:1075), the leading peer-reviewed journal for practicing endocrinologists in the US and 65 countries, reports a ground breaking discovery with the potential to reverse type 1 and 2 diabetes. Scientists ...

Monogram Announces a 6-to-1 Reverse Stock Split

SOUTH SAN FRANCISCO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., (Nasdaq: MGRM ) today announced that its Board of Directors has approved a 6-to-1 reverse split of its common stock, as previously authorized and approved by the Company's stockholders at the September ...

MedImmune Licenses Reverse Genetics Technology to Hungary's Omninvest for Use in Influenza Vaccine Development and Production

Second Agreement Signed in Third Quarter of 2008 Expands Worldwide Application of Cutting-Edge Influenza Vaccine Technology GAITHERSBURG, Md., Oct. 16 /PRNewswire/ -- MedImmune announced today that it has licensed its proprietary reverse genetics intellectual property to Omninvest, a...

Insmed to Seek Shareholder Approval for Reverse Split

RICHMOND, Va., Oct. 14 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq CM: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced that it will seek shareholder approval to implement a reverse stock split, if necessary, at a Special Meeting of Stockholders on November 2...

China Biopharma Effects 1 for 100 Reverse Stock Split

HANGZHOU, China, Sept. 15 /PRNewswire-FirstCall/ -- China Biopharma, Inc. (OTC Bulletin Board: CBPC) announced today that it has filed with the Secretary of State of the State of Delaware an amendment to its Certificate of Incorporation to effect a 1 for 100 reverse stock split. China Biopharm...

Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment

LOS ANGELES, Sept. 10 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) announced that the company's board of directors has approved a consolidation of the company's common stock to be effected in the form of a reverse stock split which will be effected as of 4:30 p.m. EST on September 19,...

Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol

LAIYANG, China, Sept. 4 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a leading pharmaceutical company in the People's Republic of China, today announced that it completed a 40-for-1 reverse stock split of it...

Cell Therapeutics, Inc. Announces Reverse Stock Split

Board of Directors approves 1-for-10 split ratio SEATTLE, Aug. 25 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that its Board of Directors has authorized a 1-for-10 reverse split of its common stock. The reverse split will become effectiv...

ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc.

IRVINE, Calif., July 1 /PRNewswire/ -- ChromaDex, Inc. ("ChromaDex"), today announced that effective June 20, 2008, it completed its merger with CDI Acquisition, Inc. ("CDI"), the wholly-owned subsidiary of Cody Resources, Inc. ("Cody") (OTC Bulletin Board: CDYE). The transaction enables Chrom...

Nanotechnology in reverse uses cell to calibrate tools

Nanotechnology researchers at UC Davis have shown that they can use a red blood cell to calibrate a sensitive instrument, an atomic force microscope. "It turns around the rules of nanotechnology, by using biology to calibrate an instrument," said Volkmar Heinrich, assistant professor in the Dep...

NuRx Pharmaceuticals Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect

IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- NuRx Pharmaceuticals, Inc. (OTC Bulletin Board: NURX pre split, NUXP post split) today announced that on May 9th, the Company's 1-for-4 reverse stock split became effective. The Company has been informed by the Over The Counter Bulletin Board's ...

CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Company's Common Stock and Trading in Post-split Shares Begins May 9, 2008

Split Intended to Maintain Nasdaq Listing and Attract Additional Investors as Company Enters Next Growth Phase SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- CardioDynamics (Nasdaq: CDIC), the innovator and leader of BioZ(R) impedance cardiography (ICG) technology, today announced ...

EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting

ROCKVILLE, Md., April 22 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that the Company's Board of Directors has decided against seeking stockhold...

Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing

BEIJING, April 18 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. ("Yongye") (OTC Bulletin Board: GDTN), a leading distributor of plant and animal nutrients headquartered in Beijing, PRC, announced today the completion of a reverse merger and share exchange transactio...

Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses

-- Lead NNRTI RDEA806 to begin Phase 2b trial in the second quarter of 2008 -- MONTREAL and SAN DIEGO, April 14 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that preclinical data was presented on the Company's next generatio...

Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences

SAN DIEGO, April 7, 2008 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that data will be presented on its second generation non-nucleoside reverse transcriptase inhibitors (NNRTIs), at the 21st International Conference on Antiviral Research (ICAR). Addition...

Phlo Reverse Stock Split Process Completed; Trading Symbol Changed to 'PHCP'

Shareholders to Surrender Certificates in Exchange for Post-Split Shares JACKSONVILLE, Fla., March 19 /PRNewswire-FirstCall/ -- Phlo Corporation (Pink Sheets: PHLC) (the "Company") announced today the completion of its 100-for-1 reverse stock split process. According to Nasdaq, the reverse spl...

Vermillion Announces Effectiveness of Reverse Stock Split

FREMONT, Calif., March 3 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML ) (the "Company"), a high-value molecular diagnostics company, announced today that on February 29, 2008, the Company filed its Third Amended and Restated Certificate of Incorporation, which effects a 1-for-10 r...

Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split

NEW HAVEN, Conn., Feb. 20 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION ) today announced that the Company would implement a one-for-ten reverse split of its common stock, effective at 5:00 p.m. Eastern Time on Wednesday, February 20, 2008. On a pre-split basis, Vion Ph...

Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections

- Activity data on lead NNRTI, RDEA806, and next generation compounds to be discussed - CARLSBAD, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that preclinical data on the Company's non-nucleoside reverse transcri...

Amarin Provides Business Update and Announces Implementation of Reverse Stock Split

LONDON, January 18 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRND ) today announced that, at a General Meeting held yesterday, its shareholders approved a 1 for 10 reverse split of each of its Ordinary Shares. The reverse split became effective as of the close of business yes...

VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal

General Meeting vote suggests broad stockholder support for proposed Raven merger SOUTH SAN FRANCISCO, Calif., Dec. 27 /PRNewswire-FirstCall/ -- VaxGen Inc. (Pink Sheets: VXGN), a biopharmaceutical company, announced today that its stockholders approved the propo...

Pharsight Announces 1-For-3 Reverse Stock Split

MOUNTAIN VIEW, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Pharsight Corporation (OTC Bulletin Board: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that its Board of Directors has approved a one- for...

Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split

Conference Call Scheduled for September 17 at 10:30 ET, 7:30 PT EMERYVILLE, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII ) today announced its financial results for its fiscal fourth quarter and year ended June 30, 2007 and announced...

Viragen International to Reverse Split Its Common Stock

- 1 for 40 Split Effective at Close of Business Today - VGNI Stock Symbol to Change to VRGE PLANTATION, Fla., Sept. 4 /PRNewswire-FirstCall/ -- Viragen International, Inc. (OTC Bulletin Board: VGNI), a majority-owned subsidiary of Viragen, Inc. (OTC Bulletin Board: VRA...

MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production

GAITHERSBURG, Md., Aug. 23 /PRNewswire/ -- MedImmune, Inc. announced today that it has licensed its proprietary reverse genetics intellectual property to Novartis to support the development and construction of new vaccine strains to produce inactivated human seasonal, pre-pandemic and pandemic...

State campaign seeks to reverse negative perception of manufacturing work

Fond du Lac, Wis. -- Careers in manufacturing are high-wage and high-tech. Yet, a future workforce shortage may be on the horizon. It appears a negative public perception - one that brings to mind low wages, assembly-line work and lay-offs - is thwarting young adults from pursuing manufacturing ca...

A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors)

Purpose In clinical research, the monitoring of protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral drugs is of significant interest due to the importance of assessing inter-individual and intra-individual metabolism variability. ...

Recombinant HIV Reverse Transcriptase

More thermostable than AMV RT and M-MLV RT Excellent target to evaluate antiviral agents Highly sensitive enzyme for RT-PCR applications Ideal for reverse transcribing transcripts with...

Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method

Occurrence of tumor cells in the peripheral blood of individuals suffering from cancer may serve as an early indication that the primary tumor has dispersed from its tissue of origin. Despite defence mechanisms of t...

Use of Transcriptor Reverse Transcriptase in Microarray Analysis

Researchers studying tissue and cellular differences in gene expression have applied microarray analysis to questions ranging from cancer research to plant development studies. Although the method is well established, many ...

Increase the Power and Sensitivity for Your cDNA Synthesis with the New Transcriptor Reverse Transcriptase

Transcriptor Reverse Transcriptase is a new recombinant reverse transcriptase (RT) expressed in E. coli. The enzyme has RNA-directed DNA polymerase activity, DNA-dependent DNA polymerase activity, unwinding activity, an...

Transcriptor Reverse Transcriptase

Increase Power and Sensitivity in cDNA Synthesis with the new Transcriptor Reverse Transcriptase With the new recombinant Transcriptor Reverse Transcriptase, you will ...

Choice of reverse transcription primers

Priming affects the size and specificity of the cDNA produced. There are three types of primers that may be used for reverse transcription: Oligo(dT)1218, which binds to the endogenous poly(A) + tail at...

C. therm. Polymerase for Reverse Transcription in Two-Step RT-PCR

Polymerase for two-step RT-PCR amplification of up to 4 kb targets Cat. No. 2 016 311 300 units Description C. therm. Polymerase provided by Roche Applied Science is the recombinant form ...

Properties of Reverse Transcriptases

Enzyme Maximum size of template Temperature optimum Units needed for standard reaction Ion require- ment Rnase H activity ...

Suggested applications for reverse transcriptases

Enzyme Full-Length cDNA High fidelity cDNA for cloning Amplification of viral RNA DDDRT a RACE a ...

OncoGenex Reports Second Quarter 2009 Financial Results

...oGenex Technologies") prior to the August 21, 2008 reverse takeover of Sonus Pharmaceuticals, Inc. ("Sonus"),...enses and higher facility costs resulting from the reverse takeover of Sonus. Reducing the expenses in the fi...n affiliate of a public company as a result of the reverse takeover, SRED claims can now only be applied agai...

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

...142,373 Accumulated deficit (1,352,870) (1,312,320) Total deficit (57,630) (132,061) (1) Amounts reflect a one-for-ten reverse stock split of our common stock effective August 31, 2008. ...